St Vincent's Hospital, Sydney

This early-stage trial is testing the safety of combining two drugs, tebentafusp and roginolisib, for people with advanced uveal melanoma, a rare and aggressive eye cancer. The study aims to find the safest and most effective dose of this combination for future research. It is fo…